|

The Vanderbilt Atrial Fibrillation Ablation Registry

RECRUITINGSponsored by Vanderbilt University
Actively Recruiting
SponsorVanderbilt University
Started2011-10
Est. completion2028-10
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT02404415

Summary

The Vanderbilt Atrial Fibrillation Ablation registry (VAFAR) is a prospective clinical and genetic biorepository that systematically enrolls patients undergoing atrial fibrillation (AF) ablation. The registry was started in 2011 and has greater than 1000 AF ablation records with stored blood and DNA samples. The goals of VAFAR are to: 1) identify clinical, genetic, and serological predictors of response to AF ablation in order to improve patient selection, and 2) to provide a resource for translational research investigating the electrophysiologic mechanisms of AF pathogenesis.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion criteria:

1. Age \>18 years
2. Able to give written, informed consent
3. Scheduled for an ablation procedure to treat atrial fibrillation

Exclusion criteria:

1\. None

Conditions2

Atrial FibrillationHeart Disease

Locations1 site

Vanderbilt University Medical Center
Nashville, Tennessee, 37232
Diane M Crawford, RN615-936-6069Diane.m.crawford@vumc.org

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.